Doxycycline Hyclate Tablet, Film Coated
Product Images NDC 24658-310

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxycycline Hyclate (NDC 24658-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puracap Laboratories Llc Dba Blu Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-210ct (Doxycycline 100mg 210ct)

The text describes a medication labeled as wZ NDC 24658-310-21. Each tablet contains Doxycycline, USP, in the form of Doxcyxyling Hyclate. The tablets should be stored at Controlled Room Temperature. The product is distributed by Puratap Laboratories, LLC, under the DBA Blue Pharmaceuticals with an expiration revision of 01.2025. The address provided is in Greenvale, NY, USA.*

FDA Label Image

100mg-50ct (Doxycycline 100mg 50ct)

This text is a description of Doxycycline Hyclate tablets, containing 100 mg of Doxycycline, USP. It provides information on the usual adult dosage, storage conditions, and dispensing requirements. The tablets are to be stored at a controlled room temperature and dispensed in a tight, light-resistant container. The product is distributed by PuraCap Laboratories, LLC, DBA Blu Pharmaceuticals.*

FDA Label Image

Structural-formula (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.